Wellington Management Group’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.8M Hold
342,353
– – ﹤0.01% 1618
2026
Q2
$2.37M Hold
342,353
– – ﹤0.01% 1591
2026
Q1
$3.08M Sell
342,353
-552,380
-62% -$9.9M ﹤0.01% 1482
2025
Q4
$24.3M Sell
894,733
-230,662
-20% -$5.74M ﹤0.01% 967
2025
Q3
$21.2M Sell
1,125,395
-99,900
-8% -$1.55M ﹤0.01% 992
2025
Q2
$13.5M Sell
1,225,295
-88,162
-7% -$814K ﹤0.01% 1112
2025
Q1
$8.03M Sell
1,313,457
-269,697
-17% -$2.58M ﹤0.01% 1258
2024
Q4
$25.6M Buy
+1,583,154
New +$35.3M ﹤0.01% 895

Other funds holding UPB

Wellington Management Group's UPB Position: Q3 2026 in Review

Wellington Management Group held its Upstream Bio (UPB) position steady in Q3 2026 at 342,353 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Wellington Management Group first reported a position in UPB in Q4 2024 and has held it in 8 quarters since. The position peaked at $25.6M in Q4 2024. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • Wellington Management Group held 342,353 shares of Upstream Bio worth $1.8M as of Q3 2026.
  • Wellington Management Group left its Upstream Bio share count unchanged in Q3 2026.
  • Upstream Bio made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1618 holding.
  • Wellington Management Group first reported a position in Upstream Bio in Q4 2024 and has held it in 8 quarters since.
  • Wellington Management Group's Upstream Bio position peaked at $25.6M in Q4 2024.
  • 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.

Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.